C-188-9

N/A

Report date: 2026/03/19 20:00:18
NME

Base Information

Drug NameC-188-9
Drug Alias NameC188-9C-188-9TTI-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitors
TargetsSignal transducer and activator of transcription 3
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisCarcinoma, Non-Small-Cell LungPancreatic Neoplasms +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBaylor College Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesWashington University School Of MedicineTvardi Therapeutics Inc
Inactive CompaniesThe University Of Texas MD Anderson Cancer Center
Active IndicationsIdiopathic Pulmonary FibrosisCarcinoma, Non-Small-Cell LungPancreatic Neoplasms +[9] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A